By promoting the activation of STAT3, TRIMs indirectly induce STAT3-target genes, such as MMP-2, MMP-9 and the vascular endothelial derived growth factor (VEGF), thus promoting cancer cell migration and invasion [220]. This evidence concerns the gene STAT3 and cancer.